Diagnostic contribution of HLA-A,B,C,DR genotyping in inflammatory joint disease

Joint Bone Spine. 2018 Oct;85(5):511-513. doi: 10.1016/j.jbspin.2018.02.007. Epub 2018 Apr 11.

Authors

Jean Roudier¹, Emmanuel Massy², Nathalie Balandraud²

Affiliations

¹ Inserm UMRs1097, arthrites autoimmunes, Aix-Marseille université, 13000 Marseille, France; Rhumatology, IML, AP-HM Marseille, 20, avenue Viton, 13274 Marseille cedex 9, France. Electronic address: [email protected].
² Inserm UMRs1097, arthrites autoimmunes, Aix-Marseille université, 13000 Marseille, France; Rhumatology, IML, AP-HM Marseille, 20, avenue Viton, 13274 Marseille cedex 9, France.

PMID: 29654946
DOI: 10.1016/j.jbspin.2018.02.007

No abstract available

Keywords: Diagnosis; HLA A,B,C,DR genotyping; Inflammatory joint disease; Psoriatic arthritis; Rheumatoid arthritis; Spondyloarthritis.

Publication types

Editorial
Review

MeSH terms

Adult
Arthritis, Rheumatoid / diagnosis
Arthritis, Rheumatoid / genetics*
Female
Genotype*
HLA-A Antigens / genetics*
HLA-B Antigens / genetics
HLA-C Antigens / genetics*
HLA-DR Antigens / genetics*
Humans
Male
Middle Aged
Prognosis
Sensitivity and Specificity
Young Adult

Substances

HLA-A Antigens
HLA-B Antigens
HLA-C Antigens
HLA-DR Antigens